LifeCell Corporation Sustainability Profile
LifeCell Corporation, a prominent player in the regenerative medicine industry, is headquartered in the United States. Founded in 1995, the company has established itself as a leader in the development of innovative tissue regeneration solutions, particularly in the fields of surgical and wound care. LifeCell is renowned for its core products, including AlloDerm® and Strattice™, which utilise advanced acellular dermal matrix technology. These unique offerings are designed to enhance healing and support tissue regeneration, setting LifeCell apart in a competitive market. With a strong presence across North America and expanding operations globally, LifeCell has achieved significant milestones, including numerous FDA approvals. The company’s commitment to quality and innovation has solidified its position as a trusted partner in the healthcare sector, making it a go-to choice for surgeons and healthcare providers alike.
DitchCarbon Score
How does LifeCell Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LifeCell Corporation's score of 36 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LifeCell Corporation, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is part of a corporate family that includes AbbVie Inc., from which it inherits climate-related commitments and initiatives. While there are no documented reduction targets or specific climate pledges from LifeCell Corporation itself, it is important to note that its climate commitments may be influenced by the broader sustainability strategies of AbbVie Inc. and Allergan plc, which are part of the same corporate structure. These parent companies have established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). As LifeCell Corporation continues to align with its parent organisations' sustainability goals, it is expected to adopt similar practices aimed at reducing carbon emissions and enhancing environmental responsibility. However, specific details regarding these initiatives or targets have not been disclosed at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2005 | 2010 | 2011 | 2012 | 2015 | 2016 | 2017 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 28,218,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 59,189,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is LifeCell Corporation's Industry?
How Carbon Intensive is LifeCell Corporation's Location?
LifeCell Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LifeCell Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
